Search Results - "Glennon, R A"

Refine Results
  1. 1

    Abuse-related and abuse-limiting effects of methcathinone and the synthetic “bath salts” cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats by Bonano, J. S., Glennon, R. A., De Felice, L. J., Banks, M. L., Negus, S. S.

    Published in Psychopharmacology (01-01-2014)
    “…Rationale Abuse of synthetic cathinones, popularized as “bath salts,” has increased dramatically in the USA since their debut in 2010. Preclinical behavioral…”
    Get full text
    Journal Article
  2. 2

    Structural Modification of the Designer Stimulant α‑Pyrrolidinovalerophenone (α-PVP) Influences Potency at Dopamine Transporters by Kolanos, R, Sakloth, F, Jain, A. D, Partilla, J. S, Baumann, M. H, Glennon, R. A

    Published in ACS chemical neuroscience (21-10-2015)
    “…α-Pyrrolidinovalerophenone (α-PVP, 7) is an illegal synthetic stimulant that is being sold on the clandestine market as “flakka” and “gravel”. The potent…”
    Get full text
    Journal Article
  3. 3

    Stereoselective Actions of Methylenedioxypyrovalerone (MDPV) To Inhibit Dopamine and Norepinephrine Transporters and Facilitate Intracranial Self-Stimulation in Rats by Kolanos, R, Partilla, J. S, Baumann, M. H, Hutsell, B. A, Banks, M. L, Negus, S. S, Glennon, R. A

    Published in ACS chemical neuroscience (20-05-2015)
    “…The designer stimulant methylenedioxypyrovalerone (MDPV) is a potent reuptake inhibitor at transporters for dopamine (DAT) and norepinephrine (NET) that…”
    Get full text
    Journal Article
  4. 4

    Pharmacophore identification for sigma-1 (sigma1) receptor binding: application of the "deconstruction-reconstruction-elaboration" approach by Glennon, R A

    Published in Mini reviews in medicinal chemistry (01-10-2005)
    “…At least two different types of sigma (sigma1 and sigma2) receptors have been identified. A structural feature common to high-affinity (Ki <10 nM) sigma1…”
    Get more information
    Journal Article
  5. 5

    Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice by Damaj, M I, Fei-Yin, M, Dukat, M, Glassco, W, Glennon, R A, Martin, B R

    “…The objective of this study was to determine which nicotinic receptor subtypes are involved in antinociception and their site of action. For that, the…”
    Get more information
    Journal Article
  6. 6

    Quantitative structure–activity relationship analysis of the pharmacology of para‐substituted methcathinone analogues by Bonano, J S, Banks, M L, Kolanos, R, Sakloth, F, Barnier, M L, Glennon, R A, Cozzi, N V, Partilla, J S, Baumann, M H, Negus, S S

    Published in British journal of pharmacology (01-05-2015)
    “…Background and Purpose Methcathinone (MCAT) is a potent monoamine releaser and parent compound to emerging drugs of abuse including mephedrone (4‐CH3 MCAT),…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para‐substituted methcathinone analogues by Sakloth, F, Kolanos, R, Mosier, P D, Bonano, J S, Banks, M L, Partilla, J S, Baumann, M H, Negus, S S, Glennon, R A

    Published in British journal of pharmacology (01-05-2015)
    “…Background and Purpose There is growing concern over the abuse of certain psychostimulant methcathinone (MCAT) analogues. This study extends an initial…”
    Get full text
    Journal Article
  9. 9

    Homoazanicotine:  A Structure-Affinity Study for Nicotinic Acetylcholine (nACh) Receptor Binding by Ferretti, G, Dukat, M, Giannella, M, Piergentili, A, Pigini, M, Quaglia, W, Damaj, M. I, Martin, B. R, Glennon, R. A

    Published in Journal of medicinal chemistry (10-10-2002)
    “…We have recently identified 3-[(1-methyl)-4,5-dihydro-1H-imidazol-2-yl)methyl]pyridine (homoazanicotine, 8) as a novel nicotinic acetylcholinergic (nACh)…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens by TITELER, M, LYON, R. A, GLENNON, R. A

    Published in Psychopharmacologia (01-02-1988)
    “…Alterations in brain serotonergic function have been implicated in the mechanism of action of LSD, mescaline, and other similarly acting hallucinogenic drugs…”
    Get full text
    Journal Article
  12. 12

    Is a nitrogen atom an important pharmacophoric element in sigma ligand binding ? by ABLORDEPPEY, S. Y, FISCHER, J. B, GLENNON, R. A

    Published in Bioorganic & medicinal chemistry (01-08-2000)
    “…A lingering question in sigma receptor ligand development is whether a nitrogen atom serves as an important pharmacophoric element in binding affinity. To…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Cathinone: An Investigation of Several N-Alkyl and Methylenedioxy-Substituted Analogs by Dal Cason, Terry A, Young, Richard, Glennon, Richard A

    Published in Pharmacology, biochemistry and behavior (01-12-1997)
    “…DAL CASON, T. A., R. YOUNG AND R. A. GLENNON. Cathinone: An investigation of several N -alkyl and methylenedioxy-substituted analogs. PHARMACOL BIOCHEM BEHAV…”
    Get full text
    Journal Article
  15. 15

    Lobeline:  Structure−Affinity Investigation of Nicotinic Acetylcholinergic Receptor Binding by Flammia, Dwight, Dukat, Malgorzata, Damaj, M. Imad, Martin, Billy, Glennon, Richard A

    Published in Journal of medicinal chemistry (09-09-1999)
    “…(−)Lobeline (1) and (−)nicotine (2) bind at neuronal nicotinic cholinergic (nACh) receptors with high affinity (K i = 4 and 2 nM, respectively). Previous…”
    Get full text
    Journal Article
  16. 16

    Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain by Appel, N M, Mitchell, W M, Garlick, R K, Glennon, R A, Teitler, M, De Souza, E B

    “…The 5-HT2 (serotonin) receptor has traditionally been labeled with antagonist radioligands such as [3H]ketanserin and [3H]spiperone, which label both agonist…”
    Get more information
    Journal Article
  17. 17

    Behavioral characterization of 2- O-desmethyl and 5- O-desmethyl metabolites of the phenylethylamine hallucinogen DOM by Eckler, J.R., Chang-Fong, J., Rabin, R.A., Smith, C., Teitler, M., Glennon, R.A., Winter, J.C.

    Published in Pharmacology, biochemistry and behavior (01-07-2003)
    “…The present investigation was undertaken to test the hypothesis that known metabolites of the phenylethylamine hallucinogen…”
    Get full text
    Journal Article
  18. 18

    Binding of nicotine and homoazanicotine analogues at neuronal nicotinic acetylcholinergic (nACh) receptors by Ferretti, G., Dukat, M., Giannella, M., Piergentili, A., Pigini, M., Quaglia, W., Damaj, M.I., Martin, B.R., Glennon, R.A.

    Published in Bioorganic & medicinal chemistry letters (24-02-2003)
    “…A total of 20 substituted analogues of nicotine ( 1a) and homoazanicotine ( 3a) were examined in order to determine whether or not they might bind in a similar…”
    Get full text
    Journal Article
  19. 19

    Investigation of hallucinogenic and related β-carbolines by Grella, Brian, Dukat, Malgorzata, Young, Richard, Teitler, Milt, Herrick-Davis, Katharine, Gauthier, Colleen B, Glennon, Richard A

    Published in Drug and alcohol dependence (01-04-1998)
    “…Certain β-carbolines are known to be hallucinogenic in humans, and several produce stimulus effects in animals similar to those of the classical hallucinogen…”
    Get full text
    Journal Article
  20. 20

    Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding by Choudhary, M S, Sachs, N, Uluer, A, Glennon, R A, Westkaemper, R B, Roth, B L

    Published in Molecular pharmacology (01-03-1995)
    “…In this paper we show that a highly conserved aromatic residue, phenylalanine at the 340-position, is essential for ergoline binding to 5-hydroxytryptamine2A…”
    Get more information
    Journal Article